Cargando…
Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
BACKGROUND: Previous studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682265/ https://www.ncbi.nlm.nih.gov/pubmed/30609983 http://dx.doi.org/10.2196/10664 |
_version_ | 1783441862114148352 |
---|---|
author | Sun, Chenglin Sun, Lin Xi, Shugang Zhang, Hong Wang, Huan Feng, Yakun Deng, Yufeng Wang, Haimin Xiao, Xianchao Wang, Gang Gao, Yuan Wang, Guixia |
author_facet | Sun, Chenglin Sun, Lin Xi, Shugang Zhang, Hong Wang, Huan Feng, Yakun Deng, Yufeng Wang, Haimin Xiao, Xianchao Wang, Gang Gao, Yuan Wang, Guixia |
author_sort | Sun, Chenglin |
collection | PubMed |
description | BACKGROUND: Previous studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile phones and personal messaging apps that have a user-friendly interface. Therefore, we designed a mobile health (mHealth) system for older people with diabetes that is based on mobile phones, has a streamlined operation interface, and incorporates maximum automation. OBJECTIVE: The goal of the research was to investigate the use of mobile phone–based telemedicine apps for management of older Chinese patients with type 2 diabetes mellitus (T2DM). Variables of interest included efficacy and safety. METHODS: A total of 91 older (aged over 65 years) patients with T2DM who presented to our department were randomly assigned to one of two groups. Patients in the intervention group (n=44) were provided glucometers capable of data transmission and received advice pertaining to medication, diet, and exercise via the mHealth telemedicine system. Patients assigned to the control group (n=47) received routine outpatient care with no additional intervention. Patients in both groups were followed up at regular 3-month intervals. RESULTS: After 3 months, patients in the intervention group showed significant (P<.05) improvement in postprandial plasma glucose level. After 6 months, patients in the intervention group exhibited a decreasing trend in postprandial plasma glucose and glycated hemoglobin levels compared with the baseline and those in the control group (P<.05). CONCLUSIONS: Mobile phone–based telemedicine apps help improve glycemic control in older Chinese patients with T2DM. TRIAL REGISTRATION: China Clinical Trial Registration Center ChiCTR 1800015214; http://www.chictr.org.cn/showprojen.aspx?proj=25949 (Archived by WebCite at http://www.webcitation.org/73wKj1GMq). |
format | Online Article Text |
id | pubmed-6682265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-66822652019-09-23 Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial Sun, Chenglin Sun, Lin Xi, Shugang Zhang, Hong Wang, Huan Feng, Yakun Deng, Yufeng Wang, Haimin Xiao, Xianchao Wang, Gang Gao, Yuan Wang, Guixia JMIR Mhealth Uhealth Original Paper BACKGROUND: Previous studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile phones and personal messaging apps that have a user-friendly interface. Therefore, we designed a mobile health (mHealth) system for older people with diabetes that is based on mobile phones, has a streamlined operation interface, and incorporates maximum automation. OBJECTIVE: The goal of the research was to investigate the use of mobile phone–based telemedicine apps for management of older Chinese patients with type 2 diabetes mellitus (T2DM). Variables of interest included efficacy and safety. METHODS: A total of 91 older (aged over 65 years) patients with T2DM who presented to our department were randomly assigned to one of two groups. Patients in the intervention group (n=44) were provided glucometers capable of data transmission and received advice pertaining to medication, diet, and exercise via the mHealth telemedicine system. Patients assigned to the control group (n=47) received routine outpatient care with no additional intervention. Patients in both groups were followed up at regular 3-month intervals. RESULTS: After 3 months, patients in the intervention group showed significant (P<.05) improvement in postprandial plasma glucose level. After 6 months, patients in the intervention group exhibited a decreasing trend in postprandial plasma glucose and glycated hemoglobin levels compared with the baseline and those in the control group (P<.05). CONCLUSIONS: Mobile phone–based telemedicine apps help improve glycemic control in older Chinese patients with T2DM. TRIAL REGISTRATION: China Clinical Trial Registration Center ChiCTR 1800015214; http://www.chictr.org.cn/showprojen.aspx?proj=25949 (Archived by WebCite at http://www.webcitation.org/73wKj1GMq). JMIR Publications 2019-01-04 /pmc/articles/PMC6682265/ /pubmed/30609983 http://dx.doi.org/10.2196/10664 Text en ©Chenglin Sun, Lin Sun, Shugang Xi, Hong Zhang, Huan Wang, Yakun Feng, Yufeng Deng, Haimin Wang, Xianchao Xiao, Gang Wang, Yuan Gao, Guixia Wang. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 04.01.2019. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Sun, Chenglin Sun, Lin Xi, Shugang Zhang, Hong Wang, Huan Feng, Yakun Deng, Yufeng Wang, Haimin Xiao, Xianchao Wang, Gang Gao, Yuan Wang, Guixia Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial |
title | Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial |
title_full | Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial |
title_fullStr | Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial |
title_full_unstemmed | Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial |
title_short | Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial |
title_sort | mobile phone–based telemedicine practice in older chinese patients with type 2 diabetes mellitus: randomized controlled trial |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682265/ https://www.ncbi.nlm.nih.gov/pubmed/30609983 http://dx.doi.org/10.2196/10664 |
work_keys_str_mv | AT sunchenglin mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT sunlin mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT xishugang mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT zhanghong mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT wanghuan mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT fengyakun mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT dengyufeng mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT wanghaimin mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT xiaoxianchao mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT wanggang mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT gaoyuan mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial AT wangguixia mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial |